AET - CVS: This Is Disgusting
CVS Health (NYSE:CVS) has once again caught our attention as a possible rebound play after reporting its earnings Feb 20th. Since then, the stock has been in free fall. Rumors of Medicare for All, and changes to pharmacy/drug reimbursements have fueled the fire. The company has lost 25% of its value in two weeks. It is over done. It is in our opinion disgusting. We are holding our noses and buying. Let us discuss.
Ok, so aside from the "what-ifs" of legislative changes, the company is strong. The earnings report was